Influence of Lipid Lowering on Impaired Coronary Flow

Condition:   Coronary Artery Disease Intervention:   Drug: atorvastatin, rosuvastatin, ezetimibe Sponsors:   Aarhus University Hospital;   HeartFlow, Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials